Long-Term Results of Tamoxifen Prophylaxis for Breast Cancer--96-Month Follow-up of the Randomized IBIS-I Trial - Concepedia

Concepedia

Publication | Open Access

Long-Term Results of Tamoxifen Prophylaxis for Breast Cancer--96-Month Follow-up of the Randomized IBIS-I Trial

DOI Full Paper Access

533

Citations

24

References

2007

Year

Jack Cuzick, JF Forbes, Ivana Šestak, Simon Cawthorn, H. Hamed, K Holli, Anthony Howell

JNCI Journal of the National Cancer Institute

Abstract

The risk-reducing effect of tamoxifen appears to persist for at least 10 years, but most side effects of tamoxifen do not continue after the 5-year treatment period.

References

	Year	Citations

Page 1